ARCHIVES

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

This article is from The Cancer Letter archive.

Vol. 15 No. 37 | September 29, 1989

Download PDF Visit The Full Archive

Related Articles

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980

NCI Test Panels Available For Marker Evaluation

March 2, 1984

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990